AIL
CLVS

AGF Investments LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

AGF Investments LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-252
Closed -$7K – 873
2018
Q3 		$7K Sell
252
-148
-37% -$5.73K ﹤0.01% 767
2018
Q2 		$19 Buy
+400
New +$19.5K ﹤0.01% 636
2018
Q1 		– Sell
-440
Closed -$29K – 838
2017
Q4 		$29K Buy
440
+210
+91% +$14.7K 0.01% 357
2017
Q3 		$20K Buy
+230
New +$18.2K ﹤0.01% 364

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

AGF Investments LLC's CLVS Position: Q4 2018 in Review

AGF Investments LLC sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 252 shares — an estimated $7K sold.

AGF Investments LLC first reported a position in CLVS in Q3 2017 and held it in 4 quarters. The position peaked at $29K in Q4 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • AGF Investments LLC reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • AGF Investments LLC sold 252 Clovis Oncology, Inc. shares in Q4 2018, an estimated $7K.
  • AGF Investments LLC first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 4 quarters.
  • AGF Investments LLC's Clovis Oncology, Inc. position peaked at $29K in Q4 2017.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on AGF Investments LLC's 13F filing for Q4 2018, filed 8 Feb 2019.